SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-015536
Filing Date
2023-06-14
Accepted
2023-06-14 16:49:24
Documents
2
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1640
2 EX-24 DOCUMENT attachment1.htm EX-24 4426
  Complete submission text file 0000899243-23-015536.txt   7583
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02109
Business Address
Renaud Ronald C JR (Reporting) CIK: 0001354434 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39311 | Film No.: 231014739

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations